English
Chinese
Cart
This product is not clubbable with other items in cart. Please remove this or other items to proceed further.
Deleting
No Items In Cart
AccelTRA® Components Program
Delivering packaging quality, speed and simplicity for generics customers
Quality
Speed
Simplicity
Proactive Technical Support
Downloadable Resources
* Requires Knowledge Center account to access.
Related Links
AccelTRA®, AccelTRA logo and Westar® are registered trademarks of West Pharmaceutical Services, Inc., in the United States and other jurisdictions.
Related Blogs
June 02, 2021
AccelTRA® Program Stoppers Mitigate Risk of Vial and Stopper Incompatibility
For any drug, selection of the appropriate primary packaging components is essential to having a containment system that ensures quality, safety, and stability. The primary packaging components are selected based on various factors, which include chemical compatibility with the drug product ingredients and dimensional fit with mating packaging components. Optimized fit among mating packaging components is essential for flawless fill-finish processing.
March 05, 2021
AccelTRA® RTS/RTU Components to Meet Premium Domestic Market Needs
To meet the ever-increasing demand of growing domestic pharmaceutical markets, the AccelTRA® Components Program has expanded to include an RTS/RTU product line with Ready-to-Sterilize (RTS) and Ready-to-Use (RTU) gamma sterilized stoppers developed to provide an innovative customer service package to help customers get their products to market quickly.
February 08, 2021
Help to Protect Your Lyophilized Drug Products – West’s AccelTRA® Components
Lyophilization (freeze drying) is the process of dehydrating a drug product at low temperature and reduced pressure. Absent water, degradation processes are greatly reduced; thus, it helps to enhance drug product stability. Moisture-sensitive drug products are often marketed in lyophilized form. For a primary package system, the selection of appropriate components is essential to prevent risks associated with alteration of the lyophilized drug product prior to reconstitution and use.
June 02, 2021
AccelTRA® Program Stoppers Mitigate Risk of Vial and Stopper Incompatibility
For any drug, selection of the appropriate primary packaging components is essential to having a containment system that ensures quality, safety, and stability. The primary packaging components are selected based on various factors, which include chemical compatibility with the drug product ingredients and dimensional fit with mating packaging components. Optimized fit among mating packaging components is essential for flawless fill-finish processing.
March 05, 2021
AccelTRA® RTS/RTU Components to Meet Premium Domestic Market Needs
To meet the ever-increasing demand of growing domestic pharmaceutical markets, the AccelTRA® Components Program has expanded to include an RTS/RTU product line with Ready-to-Sterilize (RTS) and Ready-to-Use (RTU) gamma sterilized stoppers developed to provide an innovative customer service package to help customers get their products to market quickly.
February 08, 2021
Help to Protect Your Lyophilized Drug Products – West’s AccelTRA® Components
Lyophilization (freeze drying) is the process of dehydrating a drug product at low temperature and reduced pressure. Absent water, degradation processes are greatly reduced; thus, it helps to enhance drug product stability. Moisture-sensitive drug products are often marketed in lyophilized form. For a primary package system, the selection of appropriate components is essential to prevent risks associated with alteration of the lyophilized drug product prior to reconstitution and use.
